The pooled analyses showed that the risks of all-grade neutropenia, thrombocytopenia, hypertension, hemorrhage, fatigue, anorexia, stomatitis, diarrhea, rash, HFSR were higher in patients receiving VEGFR-TKIs. This evidence concerns the gene KDR and Decreased total neutrophil count.